Navigation Links
Circassia Acquires North American and Japanese Rights to Dopexamine
Date:10/8/2008

Circassia Establishes Commercial-Scale Supply Chain

Circassia to Develop Dopexamine as Part of Proprietary Post-Surgery

Recovery Protocols

OXFORD, England, October 8 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on the fields of allergy and critical care, announced today that it has acquired the US, Canadian and Japanese development and commercialization rights to dopexamine from the international speciality pharmaceutical company Ipsen. Circassia has also entered into agreements with pharmaceutical manufacturers Excella and Hospira to establish a commercial-scale supply chain for the product.

Circassia is developing dopexamine in a new indication as an integral part of proprietary structured protocols designed to dramatically improve patient recovery following a range of high-risk surgeries. This novel approach, named ToleroCare(R), which Circassia has recently patented, combines the use of dopexamine with the administration of intra-venous fluids to improve tissue oxygenation levels during the recovery period after surgery. The precise use of fluids and dopexamine is based on carefully defined parameters such as heart stroke volume and oxygen delivery index.

ToleroCare therapy has already achieved clinical proof-of-concept in a phase II single-blind, randomized, controlled trial in 122 high-risk general surgery patients in the UK. The study showed that significantly fewer patients who received ToleroCare experienced complications in the 30 day period following surgery compared with those on standard treatment (44% vs. 68%; p = 0.003). In addition, ToleroCare patients recovered significantly quicker, staying in hospital for 17.5 days on average compared with 29.5 days (p = 0.001) for those who received standard therapy.

Dopexamine is a beta2 adrenoceptor and dopamine receptor agonist, which is approved in Europe in indications related to heart failure. Dop
'/>"/>

SOURCE Circassia Ltd
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Circassia Raises GBP11 Million ($21.8 Million) in Oversubscribed Second Round Funding
2. Circassia Initiates Phase II Clinical Study With Novel Anti-Allergy Technology
3. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
4. Neogen Acquires Kane Enterprises
5. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
6. Thermo Fisher Scientific Acquires Instrument Sales Business of Davis Inotek
7. United BioSource Acquires Interest in Leading Adaptive Design Technology Service Provider
8. NSF International Acquires David Begg Associates
9. United BioSource Acquires Caro Research, Leader in Simulation Modeling
10. Respironics Acquires Apollo Light Systems, Inc., Expands into Circadian Rhythm Device-Based Therapy Market
11. Thermo Fisher Scientific Acquires Logistics Provider to Strengthen Clinical Trials Management Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... SoundConnect is pleased to announce the release of ... Canada. Lync is the next generation of ... organizations to collaborate and communicate much more easily and ... United States. With the progressive rollout of Lync in ... SoundConnect now offers a complete Microsoft Lync solution for ...
(Date:5/21/2013)... 21, 2013 The Formulate Fusion Fabric ... for sales and marketing teams looking for a fully-functional package ... kit as “everything you’ll need to put together a stunning ... comes with a number of displays and accessories that can ... feet by 20 feet in size. These components vary from ...
(Date:5/20/2013)... -- , Collaboration with the U.S. ... in treatment of mastitis , Major ... begin in the second half 2013 ... Limited (ASX: POH, OTCQX: PPGNY) will collaborate with ... (ARS) to develop and trial products targeting the serious ...
(Date:5/20/2013)... Oven Industries Inc. announces a new laboratory ... controller has many outstanding user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, which has ... device unique, as well as highly convenient for users. ... be used universally, which allows the user to use ...
Breaking Biology Technology:SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2New Laboratory Temperature Controller by Oven Industries 2
... DIEGO, March 7, 2012  Neurocrine Biosciences, Inc. (Nasdaq: ... Chief Financial Officer of Neurocrine Biosciences, will be presenting at ... The live presentation takes place on Tuesday, March 13 ... The presentation will be webcast and may be accessed on ...
... View, a Citeline product, the leading source of commercial and ... for demonstration at the AUTM 2012 Annual meeting in Anaheim, ... to view the newly designed platform. The ... in- and out-licensing opportunities, construct product-focused timelines and identify key ...
... March 7, 2012  Today, Cobalt Technologies , ... the achievement of major progress toward commercial scale ... in cooperation with ANDRITZ , a globally ... the pulp and paper industry, tested its dilute ...
Cached Biology Technology:Be One of the First to Experience Medtrack One View at the AUTM 2012 Annual Meeting 2Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration 2Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration 3
(Date:5/19/2013)... reports that white men and women of European descent ... and lesser toe deformities, including hammer or claw toe. ... the heritability of foot disorders in humansappear in ... Wiley on behalf of the American College of Rheumatology ... as 60% of older adults have foot disorders which ...
(Date:5/18/2013)... today at Digestive Disease Week (DDW) explores new discoveries ... of coffee on autoimmune disease and palliative care for ... been associated with reduced risk of fibrosis, a new ... java each month also correlate with lower risk for ... Clinic, Rochester, MN, linked coffee consumption with reduced risk ...
(Date:5/17/2013)... noise of the South, but the night belongs to the ... heavy from the humidity and the sounds of wildlife. ... frogs, toads and salamanders, is the center of amphibian biodiversity ... the auditorium for their symphonic choruses, the scientists of the ... have front-row seats. , Amphibians, which rely on ...
Breaking Biology News(10 mins):Blame your parents for bunion woes 2Coffee consumption associated with reduced risk of autoimmune liver disease 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... medicines and the introduction of new anti-arthritis drugs ... (RA), according to guidelines issued by the American ... the University of Alabama at Birmingham (UAB). ... in the UAB Division of Clinical Immunology and ...
... University of Manchester are striving to discover how the body,s natural ... disease and nerve damage thanks to a 370,000 funding boost. ... such as skin, liver, brain and blood are surrounded ... sugars help the cells to know what type of cell they ...
... Spanish . , , Plants undergo stress because of ... or to excess of light. A research team from the ... are triggered in plants to protect themselves, with the goal ... environment during reforestation under adverse environmental conditions. Droughts, extreme ...
Cached Biology News:New guidelines for treating rheumatoid arthritis 2Sugar study is sweetener for stem cell science 2Measuring the stress of forested areas 2Measuring the stress of forested areas 3
... often call for critical, but time-consuming ... refines siRNA transfection protocols resulting in ... can be used to efficiently transfect ... without increased cytotoxicity. From start ...
... Gene silencing experiments often call for ... NeoFX Transfection Agent refines siRNA transfection ... NeoFXs lipid-based formulation can be used ... they are subcultured without increased ...
... special concentrated jetSI 10 nM is available ... mouse brain as described in: Z. Hassani, ... Giovannangeli, J.-P. Behr, and B.-A. Demeneix. Lipid-mediated ... in the mouse brain at picomolar levels. ...
... fluorescein-conjugated jetSI-ENDO (excitation at ... nm), the powerful siRNA transfection ... to determine the transfection efficiency ... and trafficking of siRNAs. More ...
Biology Products: